Larvol Delta - A-Phase-III-Dosefinding-Study-to-Assess-the-Safety-Reactogenicity-and-Immunogenicity-of-a-Broadly-Protective-Sarbecovirus-Vaccine-GBP511-in-Healthy-Adults

Comirnaty (tozinameran) - Pfizer, BioNTech

http://clinicaltrials.gov/ct2/show/NCT07280858

Sep 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next